We are live on
!
Find out more
Immunic
IMUX
IMUX
57 hedge funds and large institutions have $65.6M invested in Immunic in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 6
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
36% more funds holding
Funds holding: 42 → 57 (+15)
27% more capital invested
Capital invested by funds: $51.7M → $65.6M (+$13.9M)
0% more ownership
Funds ownership: 0.06% → 0.07% (+0%)
97% less call options, than puts
Call options by funds: $14K | Put options by funds: $454K
Holders
57
Holders Change
+15
Holders Change %
+35.71%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
17
Reduced
7
Closed
6
Calls
$14K
Puts
$454K
Net Calls
-$440K
Net Calls Change
-$333K
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.51M |
| 2 |
Millennium Management
New York
|
-$955K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$478K |
| 4 |
DY
Dowling & Yahnke
San Diego,
California
|
-$252K |
| 5 |
ECM
Element Capital Management
New York
|
-$179K |
